Ironwood Pharmaceuticals | IRWD - Gross Profit On Sales

Stock Price
4.57
Daily Change
0.12 2.70%
Monthly
12.01%
Yearly
168.82%
Q1 Forecast
4.74

Ironwood Pharmaceuticals reported $85.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 256.99M 13.15M Sep/2025
Agios Pharmaceuticals USD 11.2M 448K Sep/2025
Alnylam Pharmaceuticals USD 1.05B 418.14M Sep/2025
Amarin USD 22.21M 28.15M Sep/2025
Ardelyx USD 106.35M 23.51M Sep/2025
Astellas Pharma JPY 456.81B 38.02B Dec/2025
AstraZeneca USD 12.39B 406M Sep/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Incyte USD 1.27B 130.22M Sep/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
MacroGenics USD 61.25M 88.71M Sep/2025
Moderna USD 809M 791M Sep/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Pacira USD 130.92M 5M Sep/2025
PTC Therapeutics USD 187.69M 24.3M Sep/2025
Sarepta Therapeutics USD 247.9M 209.96M Sep/2025
Takeda JPY 790.55B 262.97B Dec/2025
Ultragenyx Pharmaceutical USD 131.94M 11.55M Sep/2025